Neurobo Pharmaceuticals Financials

Neurobo Pharmaceuticals Stock Summary

Neurobo Pharmaceuticals competes with Allarity Therapeutics, Virax Biolabs, Quoin Pharmaceuticals, Biodexa Pharmaceticals, and Zura Bio. NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company that develops and commercializes multimodal disease-modifying therapies for viral, neuropathic, and neurodegenerative diseases. NeuroBo Pharmaceuticals, Inc. is headquartered in Boston, Massachusetts. Neurobo Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 5 people.

Neurobo Pharmaceuticals Key Financial Ratios

Neurobo Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Neurobo Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Neurobo Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Neurobo Pharmaceuticals competition to find correlations between indicators driving Neurobo Pharmaceuticals's intrinsic value. More Info.Neurobo Pharmaceuticals is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Neurobo Pharmaceuticals' earnings, one of the primary drivers of an investment's value.

Neurobo Pharmaceuticals Systematic Risk

Along with financial statement analysis, the daily predictive indicators of Neurobo Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Neurobo Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Neurobo Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Neurobo Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Neurobo Pharmaceuticals's daily price indicators and compare them against related drivers.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neurobo Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

If you are still planning to invest in Neurobo Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Neurobo Pharmaceuticals' history and understand the potential risks before investing.